Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | helix-loop-helix DNA-binding domain-containing protein | 0.0071 | 0.2563 | 0.3471 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0099 | 0.3884 | 0.5317 |
Echinococcus granulosus | GPCR family 2 | 0.0027 | 0.0527 | 0.1173 |
Echinococcus multilocularis | GPCR, family 2 | 0.0027 | 0.0527 | 0.1173 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2023 | 0.2716 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0027 | 0.0527 | 0.0624 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0079 | 0.2934 | 0.3989 |
Loa Loa (eye worm) | hypothetical protein | 0.0087 | 0.3313 | 0.4519 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Echinococcus granulosus | transcription factor eb | 0.0071 | 0.2579 | 0.657 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0018 | 0.0081 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.3884 | 1 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0018 | 0.0081 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.3884 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0059 | 0.2023 | 0.2716 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0018 | 0.0081 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0118 | 0.4766 | 0.6551 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0027 | 0.0527 | 0.1173 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0087 | 0.3313 | 0.4519 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0087 | 0.3313 | 0.4519 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.0527 | 0.1358 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Brugia malayi | Helix-loop-helix DNA-binding domain containing protein | 0.0071 | 0.2579 | 0.3493 |
Brugia malayi | MH2 domain containing protein | 0.0079 | 0.2934 | 0.3989 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0099 | 0.3884 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0099 | 0.3884 | 0.5317 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0099 | 0.3884 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0027 | 0.0527 | 0.0624 |
Schistosoma mansoni | hypothetical protein | 0.0059 | 0.2023 | 0.521 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0027 | 0.0527 | 0.1173 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.017 | 0.7233 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0065 | 0.23 | 0.2237 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.0527 | 0.1358 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0527 | 0.0624 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0018 | 0.0081 | 0.5 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0118 | 0.4766 | 0.6551 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0099 | 0.3884 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.017 | 0.7233 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0099 | 0.3884 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2563 | 0.3471 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0079 | 0.2934 | 0.3989 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0027 | 0.0527 | 0.1173 |
Plasmodium falciparum | flap endonuclease 1 | 0.0018 | 0.0081 | 0.5 |
Entamoeba histolytica | Rad52/22 family double-strand break repair protein, putative | 0.0065 | 0.23 | 0.2237 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0087 | 0.3313 | 0.4519 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0112 | 0.4484 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0027 | 0.0527 | 0.1173 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0112 | 0.4484 | 0.6156 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0027 | 0.0527 | 0.0624 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0099 | 0.3884 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.0527 | 0.1358 |
Echinococcus multilocularis | transcription factor eb | 0.0071 | 0.2579 | 0.657 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0018 | 0.0081 | 0.5 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.017 | 0.7233 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0027 | 0.0527 | 0.1358 |
Giardia lamblia | DNA repair protein RAD52 | 0.0229 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.799 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.754 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.726 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.708 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.693 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.407 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.192 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.883 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.849 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.791 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.776 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.